Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis

Articolo

Data di Pubblicazione:

2012

Citazione:

Ferraccioli, G., Tolusso, B., Bobbio Pallavicini, F., Gremese, E., Ravagnani, V., Benucci, M., Podestà, E., Atzeni, F., Mannocci, A., Biasi, D., Manfredi, M., Sarzi Puttini, P., Laganà, B., Montecucco, C., Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis, <>, 2012; 7 (7): e40362-e40369. [doi:10.1371/journal.pone.0040362] [http://hdl.handle.net/10807/31456]

Abstract:

To find out whether a high number of auto-antibodies can increase the probability of a "good-EULAR response" and to identify the possible biomarkers of response in seropositive rheumatoid arthritis (RA) patients undergoing the B cell depletion therapy (BCDT).

Tipologia CRIS:

Articolo in rivista, Nota a sentenza

Keywords:

rheumatoid arthritis; B cells

Elenco autori: